AbbVie Seeks at Least $8 Billion in Debt to Fund Apogee Deal
AbbVie Inc. is seeking to raise at least $8 billion from an investment-grade bond offering to fund a portion of its acquisition of Apogee Therapeutics Inc.
This is a summary aggregated from Bloomberg Markets. Read the complete article on the original site:
Read full article at Bloomberg Markets
